Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial

Dipankar Sircar; Soumya Chatterjee; Rajesh Waikhom; Vishal Golay; Arpita Raychaudhury; Suparna Chatterjee; Rajendra Pandey

doi:10.1053/j.ajkd.2015.05.017

Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial

Dipankar Sircar(Institute of Post Graduate Medical Education and Research), Soumya Chatterjee(Institute of Post Graduate Medical Education and Research), Rajesh Waikhom(Institute of Medical Sciences), Vishal Golay(Institute of Post Graduate Medical Education and Research), Arpita Raychaudhury(Institute of Post Graduate Medical Education and Research), Suparna Chatterjee(Institute of Post Graduate Medical Education and Research), Rajendra Pandey(Institute of Post Graduate Medical Education and Research)

American Journal of Kidney Diseases

July 30, 2015

10.1053/j.ajkd.2015.05.017

Cited by 320Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis